BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3028539)

  • 1. Cell surface phenotyping of megakaryoblasts.
    Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
    Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts.
    Koike T
    Blood; 1984 Sep; 64(3):683-92. PubMed ID: 6087961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
    San Miguel JF; Gonzalez M; Cañizo MC; Ojeda E; Orfao A; Caballero MD; Moro MJ; Fisac P; Lopez Borrasca A
    Blood; 1988 Aug; 72(2):402-7. PubMed ID: 3165292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
    Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
    Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
    Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
    Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory anemia terminating in acute megakaryoblastic leukemia (M7).
    Adachi M; Ryo R; Yoshida A; Yamaguchi N; Izumi Y
    Acta Haematol; 1989; 81(2):104-8. PubMed ID: 2496548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
    Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
    Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
    Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
    Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of platelet-associated antigen and platelet peroxidase on buffy coat cells from bone marrow in two patients with pediatric acute megakaryocytic leukemia.
    Kinugawa N; Okimoto Y; Hata J
    J Pediatr Hematol Oncol; 1999; 21(5):451-2. PubMed ID: 10524465
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
    Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
    Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and distribution of megakaryoblasts in FAB subtypes of ANLL: an immunocytochemical ultrastructural study.
    Tomasi P; Tallarico A; Vasi V; Scapoli G; Castoldi G
    Haematologica; 1993; 78(2):95-100. PubMed ID: 7688710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.
    Umiel T; Nadler LM; Cohen IJ; Levine H; Stark B; Mammon Z; Dzaldetti M; Rechavi G; Simoni F; Katzir N
    Cancer; 1987 Mar; 59(6):1143-9. PubMed ID: 3102033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
    Chisholm KM; Rivetta CV; Heerema-McKenney A
    Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmortem diagnosis of acute megakaryocytic leukemia. Usefulness of immunohistochemistry and tissue hemogram.
    Umezawa A; Yamada T; Ogawa Y; Kuramochi S; Watanabe Y
    Acta Pathol Jpn; 1990 Sep; 40(9):693-8. PubMed ID: 2260477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction.
    Yasunaga M; Ryo R; Sugano W; Yamaguchi N
    Leuk Lymphoma; 1992 Aug; 7(5-6):505-10. PubMed ID: 1493450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute leukemia with active hemophagocytosis, positive immunologic markers for the megakaryocyte-platelet lineage, and translocation (16; 21) (p11; q22].
    Shimizu H; Ui T; Kawai S; Kaneko Y; Fujimoto T
    Rinsho Ketsueki; 1990 Jan; 31(1):70-4. PubMed ID: 2313908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoleukemia in Down's syndrome. Analysis of immunophenotype and gene rearrangement.
    Domenico DR; Dizikes GJ; Melnyk AR; Bird ML; Suarez CR; Schumacher HR
    Am J Clin Pathol; 1989 Jun; 91(6):709-14. PubMed ID: 2524966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia.
    Matolcsy A; Kálmán E; Pajor L; Kónya T; Weber E
    Leuk Res; 1991; 15(10):887-97. PubMed ID: 1921449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.